Skip to main content
Caplight Logo









DeepPath

DeepPath

Private
ManchesterHealthcare & Life Scienceshttps://www.deeppath.io/

Last Round

Accelerator

Sep 22, 2022

Total Funding Raised

$1.27M

Company Overview

DeepPath is a MedTech company that develops AI-powered decision support systems for digital pathology to assist histopathologists in cancer staging and diagnostic processes.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Healthcare Analytics, Computer Vision

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Keywords

digital pathologycomputational pathologyclinical decision supportAI pathologyhistopathology AIwhole-slide imagingWSImetastasis detectionmedical imaging AIpathology workflowusage-based SaaSmedical device softwarepathology lab automationdiagnostic software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DeepPath Comparables

Compare DeepPath with similar companies based on industry and business-model similarity.

DeepPath comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ibex Medical Analytics
80%
MindPeak
79%
Aiforia
79%

DeepPath Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorSep 22, 2022
GrantMay 6, 2022
GrantDec 1, 2017

DeepPath Investors

Notable investors and investment history

DeepPath investors
InvestorRounds
European Innovation Council FundGrant
SBRI HealthcareGrant
National Bank of GreeceAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 22, 2022

    National Bank of Greece participated in the round.

  • May 6, 2022

    $1.27M grant received from European Innovation Council Fund.

DeepPath Filings

Explore SEC and related filing metadata, where available.

DeepPath filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about DeepPath's valuation, stock price, and market status.

Is DeepPath a public or private company?

DeepPath is a private company.

What is the current stock price of DeepPath?

DeepPath is a private company with no public stock price. No recent secondary market data is available.

How much is DeepPath worth (valuation)?

Valuation information for DeepPath is not publicly available.

Can I buy DeepPath stock?

DeepPath shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was DeepPath's last funding round?

DeepPath's most recent funding round was Accelerator on September 22, 2022.

Who are the main investors in DeepPath?

Key investors in DeepPath include European Innovation Council Fund, SBRI Healthcare, National Bank of Greece.

Will DeepPath IPO soon?

No public IPO plans have been announced for DeepPath.

How can I track DeepPath secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor DeepPath's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersManchester
Year Founded2017
Last FundingSep 22, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?